BUSETTO, GIAN MARIA
 Distribuzione geografica
Continente #
NA - Nord America 3.757
EU - Europa 1.056
AS - Asia 749
AF - Africa 28
SA - Sud America 16
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.609
Nazione #
US - Stati Uniti d'America 3.715
IT - Italia 486
SG - Singapore 290
IN - India 204
CN - Cina 175
SE - Svezia 116
DE - Germania 83
FI - Finlandia 77
UA - Ucraina 70
ID - Indonesia 50
GB - Regno Unito 48
CA - Canada 39
BG - Bulgaria 35
FR - Francia 30
IE - Irlanda 25
TG - Togo 23
PL - Polonia 18
BE - Belgio 17
AR - Argentina 13
RO - Romania 13
NL - Olanda 9
CH - Svizzera 8
AL - Albania 5
RU - Federazione Russa 5
TR - Turchia 5
IR - Iran 4
KR - Corea 4
ES - Italia 3
JP - Giappone 3
VN - Vietnam 3
ZA - Sudafrica 3
AU - Australia 2
BR - Brasile 2
BZ - Belize 2
GR - Grecia 2
HK - Hong Kong 2
IQ - Iraq 2
MK - Macedonia 2
AT - Austria 1
AZ - Azerbaigian 1
CO - Colombia 1
CZ - Repubblica Ceca 1
EG - Egitto 1
EU - Europa 1
IL - Israele 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
MO - Macao, regione amministrativa speciale della Cina 1
PH - Filippine 1
PT - Portogallo 1
RS - Serbia 1
SC - Seychelles 1
UZ - Uzbekistan 1
Totale 5.609
Città #
Fairfield 591
Ashburn 294
Chandler 284
Woodbridge 277
Seattle 241
Houston 237
Wilmington 229
Singapore 205
Cambridge 177
Rome 151
Ann Arbor 148
Princeton 109
San Paolo di Civitate 95
Beijing 79
Lawrence 75
Santa Clara 70
Plano 58
Millbury 54
Jakarta 50
Boston 49
San Diego 45
Dearborn 38
Sofia 35
Helsinki 30
Andover 27
Milan 27
Jacksonville 23
Lomé 23
Norwalk 21
Dublin 20
Toronto 19
Des Moines 18
Brussels 17
Grafing 17
Ottawa 16
Boardman 14
Dallas 14
New York 14
Warsaw 14
Munich 13
Federal 12
Guangzhou 11
Napoli 11
Stockholm 11
Falls Church 10
Kunming 10
Phoenix 10
Bühl 9
Hefei 9
Nanjing 9
Falkenstein 8
Bern 7
Ercolano 7
Frankfurt am Main 7
Fremont 7
Nanchang 7
Southend 7
Auburn Hills 6
Cagliari 6
Los Angeles 6
Columbus 5
Lappeenranta 5
San Jose 5
Genova 4
Jinan 4
L’Aquila 4
Mannheim 4
Naples 4
Pune 4
Shanghai 4
Tirana 4
Turin 4
Buffalo 3
Changsha 3
Chiswick 3
Hebei 3
London 3
Mcallen 3
Montréal 3
Prineville 3
San Mateo 3
Valencia 3
Wuhan 3
Zhengzhou 3
Acquaviva delle Fonti 2
Bayreuth 2
Belize City 2
Buccinasco 2
Casamassima 2
Cavallino-Treporti 2
Città di Castello 2
Fort Worth 2
Gessate 2
Guardiagrele 2
Gwangjin-gu 2
Helsingborg 2
Hounslow 2
Indiana 2
Istanbul 2
Jinhua 2
Totale 4.207
Nome #
Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer 147
Chronic bacterial prostatitis: efficacy of short-lasting antibiotic therapy with prulifloxacin (Unidrox®) in association with saw palmetto extract, lactobacillus sporogens and arbutin (Lactorepens®) 140
null 108
Circulating tumor cells identify patients with super-high-risk non-muscle-invasive bladder cancer: updated outcome analysis of a prospective single-center trial 101
Prostate imaging reporting and data system 3 category cases at multiparametric magnetic resonance for prostate cancer. A systematic review and meta-analysis 101
Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor 93
CIRCULATING TUMOR CELLS AND THEIR PROGNOSTICSIGNIFICANCE IN NON MUSCLE INVASIVE BLADDER CANCER:A CELLSEARCH ANALYSIS. 89
Knotless "three-U-stitches" technique for urethrovesical anastomosis during laparoscopic radical prostatectomy 88
Psychological impact of different primary treatments for prostate cancer. a critical analysis 88
A NEW MOLECULAR CHEMOSENSITIVITY TEST TO IMPROVE AND PREDICT EFFICACY OF INTRAVESICAL ADJUVANTTHERAPY IN NMIBC (NON MUSCLE INVASIVE BLADDER CANCER) 83
Primary Metastatic Neuroendocrine Small Cell Bladder Cancer: A Case Report and Literature Review 80
A systematic review and meta-analysis of clinical trials implementing aromatase inhibitors to treat male infertility 78
Risk decrease of intra-operative bleeding during TURP with the uptake of Finasteride: Evaluation of VEGF and CD34. 77
Circulating tumor cells detection has independent prognostic impact in high-risk non-muscle invasive bladder cancer 77
The long-term prognostic value of survivin expressing circulating tumor cells in patients with high-risk non-muscle invasive bladder cancer (NMIBC) 76
Distal corporal anchoring stitch: a technique to address distal corporal crossovers and impending lateral extrusions of a penile prosthesis 75
Adding systematic biopsy to magnetic resonance ultrasound fusion targeted biopsy of the prostate in men with previous negative biopsy or enrolled in active surveillance programs 73
Cribriform pattern does not have a significant impact in Gleason Score ≥7/ISUP Grade ≥2 prostate cancers submitted to radical prostatectomy 72
Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance 71
Biomarkers in prostate cancer diagnosis: from current knowledge to the role of metabolomics and exosomes 68
Studio prospettico sull’efficacia e la tollerabilità di un integratore alimentare nei pazienti affetti da infertilità primaria con astenoteratozoospermia idiopatica 67
Impact of uni- or multifocal perineural invasion in prostate cancer at radical prostatectomy 67
Modeling the contribution of male testosterone levels to the duration of positive COVID testing among hospitalized male COVID-19 patients 67
Incidental prostatic stromal tumor of uncertain malignant potential (STUMP): histopathological and immunohistochemical findings. 67
Efficacy and safety of finasteride (5 alpha-reductase inhibitor) monotherapy in patients with benign prostatic hyperplasia. a critical review of the literature 66
Prostate Cancer Gene 3 and Multiparametric Magnetic Resonance Can Reduce Unnecessary Biopsies: Decision Curve Analysis to Evaluate Predictive Models 65
High risk non-muscle invasive bladder cancer: prognostic factor of circulating tumour cells. 65
Comparison of 10-year overall survival between patients with G1 and G2 grade Ta bladder tumors 65
Recurrent transitional cell carcinoma of the bladder: A mixed nested variant case report and literature review. 64
Postoperative vacuum therapy following AMS™ LGX 700® inflatable penile prosthesis placement: penile dimension outcomes and overall satisfaction 63
Sling uretrale con tecnica transutturatoria (TOT) nell’incontinenza urinaria da sforzo (IUS): valutazione dei risultati con follow-up di 5 anni 62
Reduced intraoperative bleeding during transurethral resection of the prostate: Evaluation of finasteride, vascular endothelial growth factor, and CD34 62
Contemporary trends of systemic neoadjuvant and adjuvant intravesical chemotherapy in patients with upper tract urothelial carcinomas undergoing minimally invasive or open radical nephroureterectomy: analysis of US claims on perioperative outcomes and health care costs 62
Body mass index and age correlate with antioxidant supplementation effects on sperm quality: Post hoc analyses from a double-blind placebo-controlled trial 61
Comparison of the clinical usefulness of different urinary tests for the initial detection of bladder cancer: a systematic review 61
T1G3 high-risk NMIBC (non-muscle invasive bladder cancer): conservative treatment versus immediate cystectomy 60
Double-blind, randomised, placebo-controlled trial on the effect of L-carnitine and L-acetylcarnitine on sperm parameters in men with idiopathic oligoasthenozoospermia 58
Safety and feasibility of outpatient surgery in benign prostatic hyperplasia: a systematic review and meta-analysis 58
Predictors of residual T1 high grade on re-transurethral resection in a large multi-institutional cohort of patients with primary T1 high-grade/grade 3 bladder cancer 57
Validation of neutrophil-to-lymphocyte ratio in a multi-institutional cohort of patients with T1G3 non–muscle-invasive bladder cancer 56
Epigenetic signature: a new player as predictor of clinically significant Prostate Cancer (PCa) in patients on Active Surveillance (AS) 55
SelectMDx and multiparametric magnetic resonance imaging of the prostate for men undergoing primary prostate biopsy: a prospective assessment in a multi-institutional study 55
Effect of metabolic and antioxidant supplementation on sperm parameters in oligo-astheno-teratozoospermia, with and without varicocele: a double-blind placebo-controlled study 54
Male Oxidative Stress Infertility (MOSI): Proposed Terminology and Clinical Practice Guidelines for Management of Idiopathic Male Infertility 54
Prognostic factor of circulating tumor cells in high risk non-muscle invasive bladder cancer 54
Gemcitabina endovescicale nelle NMIBC: valutazione degli effetti collaterali ed analisi farmacodinamica 53
null 53
Tissue resonance interaction method probe (TRIMPROB TM) a new diagnosis of prostate cancer. 53
High-grade T1 on re-transurethral resection after initial high-grade T1 confers worse oncological outcomes. Results of a multi-institutional study 53
Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy 52
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer 52
Hyperhomocysteinemia as an early predictor of erectile dysfunction: International index of erectile function (IIEF) and penile doppler ultrasound correlation with plasma levels of homocysteine 52
Non-ischemic priapism following recurrent idiopathic ischemic priapism treated successfully with selective arterial embolization and postoperative vacuum therapy before delayed inflatable penile prosthesis placement. a single case report 52
How Can the COVID-19 Pandemic Lead to Positive Changes in Urology Residency? 52
Surgical blood loss during holmium laser enucleation of the prostate (holep) is not affected by short-term pretreatment with dutasteride. a double-blind placebo-controlled trial on prostate vascularity 51
Predictive value of MCM5 (ADXBLADDER) analysis in urine of men evaluated for the initial diagnosis of bladder cancer: a comparative prospective study 51
Association between male infertility and male-specific malignancies: systematic review and meta-analysis of population-based retrospective cohort studies 51
Prognostic value of circulating tumor cells in nonmuscle invasive bladder cancer: a CellSearch analysis. 51
EVALUATION AND PROGNOSTIC FACTOR OF CIRCULATING TUMOR CELL IN NMIBC (NON-MUSCLE INVASIVE BLADDER CANCER) 50
null 50
null 50
The clinical efficacy of nitrofurantoin for treating uncomplicated urinary tract infection in adults: a systematic review of randomized control trials 50
PSA Density Help to Identify Patients With Elevated PSA Due to Prostate Cancer Rather Than Intraprostatic Inflammation: A Prospective Single Center Study. 49
HIGH-RISK NMIBC (NON-MUSCLE INVASIVE BLADDERCANCER): PROGNOSTIC VALUE OF CIRCULATINGTUMOR CELLS 49
A Biofeedback guided program or pelvic floor muscle electric stimulation can improve early recovery of urinary continence after radical prostatectomy: a meta-analysis and systematic review 48
SARS-CoV-2 infection and high-risk non-muscle-invasive bladder cancer: are there any common features? 46
NEW PROTOCOL OF CT CYSTOGRAPHY (CTC) WITH DUAL SOURCE TECHNIQUE IN DETECTION OF BLADDER LESION 46
SURVIVIN EXPRESSING CIRCULATING TUMOR CELLS IN NONMUSCHE INVASIVE BLADDER CANCER: A CELLECTION™ DYNABEADS ANALYSIS 45
A systematic review and meta-analysis of randomized controlled trials with novel hormonal therapies for non-metastatic castration-resistant prostate cancer: an update from mature overall survival data 45
Prospective comparative trial on nerve-sparing radical prostatectomy using a robot-assisted versus laparoscopic technique: expectation versus satisfaction and impact on surgical margins 44
Predictive role of node-rads score in patients with prostate cancer candidates for radical prostatectomy with extended lymph node dissection: comparative analysis with validated nomograms 44
COMBINATION THERAPY OF ETHINYLESTRADIOL AND ESTRAMUSTINE PHOSPHATE REINTRODUCES OBJECTIVE CLINICAL RESPONSE IN PATIENTS WITH ANDROGEN ABLATION-REFRACTORY PROSTATE CANCER (EARLY EXPERIENCE) 43
Modified glasgow prognostic score is associated with risk of recurrence in bladder cancer patients after radical Cystectomy. A multicenter experience 43
Circulating preoperative testosterone level predicts unfavourable disease at radical prostatectomy in men with International Society of Urological Pathology Grade Group 1 prostate cancer diagnosed with systematic biopsies 43
Efficacy of three BCG strains (Connaught, TICE and RIVM) with or without secondary resection (re-TUR) for intermediate/high-risk non-muscle-invasive bladder cancers: results from a retrospective single-institution cohort analysis 42
Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor 40
Prostate Cancer Gene 3 and Multiparametric Magnetic Resonance Can Reduce Unnecessary Biopsies: Decision Curve Analysis to Evaluate Predictive Models Reply 40
MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING OF THE PROSTATE AND PCA3 URINARY TEST: IS TIME TO RE-EVALUATE PROSTATE BIOPSY? 39
Elective procedures for prostate cancer in the time of Covid-19. a multidisciplinary team experience 39
Prospective assessment of two-gene urinary test with multiparametric magnetic resonance imaging of the prostate for men undergoing primary prostate biopsy 38
Preoperative detection of Vesical Imaging-Reporting and Data System (VI-RADS) score 5 reliably identifies extravesical extension of urothelial carcinoma of the urinary bladder and predicts significant delayed time to cystectomy: time to reconsider the need for primary deep transurethral resection of bladder tumour in cases of locally advanced disease? 38
Urology in the time of Coronavirus. Reduced access to urgent and emergent urological care during the coronavirus disease 2019 outbreak in Italy 37
Liquid biopsy biomarkers in urine: a route towards molecular diagnosis and personalized medicine of bladder cancer 37
inflatable penile prosthesis placement, scratch technique and postoperative vacuum therapy as a combined approach to definitive treatment of Peyronie's disease 37
Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicentre study 36
Increased mortality among men diagnosed with impaired fertility: analysis of US claims data 35
Extracorporeal shock wave therapy in the treatment of Peyronie's disease: long-term results. 33
SMALL CELL CARCINOMA OF THE URINARY BLADDER: REVIEW OF THE LITERATURE AND PRESENTATION OF A CASE REPORT 32
Modified Glasgow Prognostic Score as a predictor of recurrence in patients with high grade non-muscle invasive bladder cancer undergoing intravesical bacillus Calmette–Guerin immunotherapy 32
PCA3 urinary test versus 1H-MRSI and DCEMR in the detection of prostate cancer foci in patients with biochemical alterations 31
Prostate cancer radiogenomics - from imaging to molecular characterization 31
COMBINATION THERAPY OF ETHINYLESTRADIOL AND ESTRAMUSTINE PHOSPHATO REINTRODUCES OBJECTIVE CLINICAL RESPONSES IN PATIENTS WITH CASTRATE-RESISTANT PROSTATE CANCER 29
Radiogenomics in renal cancer management—current evidence and future prospects 28
PCA3 URINARY TEST VERSUS 3T 1H-MRS AND DCE-MRI IN THE DETECTION OF PROSTATE CANCER FOCI IN PATIENTS WITH BIOCHEMICAL ALTERATIONS 28
Syndromic infertility 28
Modeling the contribution of the obesity epidemic to the temporal decline in sperm counts 28
null 27
null 27
Neoplasie della vescica non muscolo invasive ad alto rischio sottoposte ad immunoterapia endovescicale con BCG: valutazione della risposta attraverso il dosaggio delle citochine urinarie. 26
Prospective open-label study on the efficacy and tolerability of a combination of nutritional supplements in primary infertile patients with idiopathic astenoteratozoospermia 25
Totale 5.594
Categoria #
all - tutte 21.184
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.184


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020854 0 0 0 0 0 157 156 162 140 92 110 37
2020/2021792 59 63 90 77 14 20 15 35 69 107 202 41
2021/20221.166 40 52 100 28 159 85 46 113 89 65 208 181
2022/20231.049 211 230 35 107 118 96 8 79 93 9 44 19
2023/2024606 41 102 22 59 69 68 27 51 0 67 42 58
2024/2025499 51 62 90 121 114 61 0 0 0 0 0 0
Totale 5.973